Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $DFTX vs $INDV | Chartloom

Compare

$DFTX vs $INDV

Definium Therapeutics Inc · Indivior Pharmaceuticals, Inc

DFTX

Definium Therapeutics Inc

INDV

Indivior Pharmaceuticals, Inc

Compare $DFTX vs $INDV

Comparing Definium Therapeutics Inc and Indivior Pharmaceuticals, Inc

DFTXDefinium Therapeutics Inc

INDVIndivior Pharmaceuticals, Inc

DFTXDefinium Therapeutics Inc

Market cap

$4.28B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

152.1%

52W performance

191.1%

FCF yield

-3.9%

INDVIndivior Pharmaceuticals, Inc

Market cap

$4.29B

P/E (TTM)

12.37x

Forward P/E (NTM)

7.50x

Forward P/S (NTM)

3.13x

Rev growth (TTM)

13.6%

YTD performance

-0.9%

52W performance

48.9%

FCF yield

-2.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DFTX

INDV

Detailed metrics comparison

DFTX

Definium Therapeutics Inc

INDV

Indivior Pharmaceuticals, Inc

Market Cap

DFTX$4.28B

INDV$4.29B

Enterprise Value

DFTX$3.67B

INDV$4.55B

Price

DFTX$34.38

INDV$35.42

P/E Ratio

DFTXN/A

INDV12.37x

P/S Ratio

DFTX0.00x

INDV3.22x

EV/Sales

DFTX0.00x

INDV3.42x

EV/EBITDA

DFTX0.00x

INDV10.26x

P/B Ratio

DFTX5.40x

INDV422.91x

P/FCF Ratio

DFTXN/A

INDVN/A

EV/FCF

DFTX-21.83x

INDV-41.75x

PEG Ratio

DFTXN/A

INDV0.41x

Forward P/E (NTM)

DFTXN/A

INDV7.50x

Forward P/S (NTM)

DFTXN/A

INDV3.13x

Revenue (TTM)

DFTX$0

INDV$1.33B

Revenue Growth (YoY)

DFTXN/A

INDV13.6%

Forward Rev Growth

DFTX717.7%

INDV5.4%

Gross Margin (TTM)

DFTX0.0%

INDV82.0%

Operating Margin (TTM)

DFTX0.0%

INDV30.3%

EBITDA Margin (TTM)

DFTX0.0%

INDV33.1%

Net Margin (TTM)

DFTX0.0%

INDV26.7%

FCF Margin (TTM)

DFTXN/A

INDV-8.2%

Net Income (TTM)

DFTX$-354M

INDV$355M

FCF (TTM)

DFTX$-168M

INDV$-109M

EPS (TTM)

DFTX-$3.20

INDV$2.86

ROE (TTM)

DFTX-8523.0%

INDV159.1%

ROA (TTM)

DFTX-6458.0%

INDV28.1%

ROIC (TTM)

DFTX-7781.0%

INDV29.4%

Cash

DFTX$655M

INDV$222M

Debt

DFTX$36M

INDV$487M

Net Cash/Debt

DFTX$619M

INDV$-265M

Current Ratio (TTM)

DFTX6.95x

INDV0.84x

Quick Ratio (TTM)

DFTX6.89x

INDV0.65x

Debt/Equity (TTM)

DFTX0.04x

INDV27.90x

Debt/Assets (TTM)

DFTX0.0%

INDV0.0%

Interest Coverage (TTM)

DFTXN/A

INDVN/A

Net Debt/EBITDA (TTM)

DFTX0.00x

INDV0.00x

Beta

DFTX2.23

INDV0.49

52W Performance

DFTX191.1%

INDV48.9%

YTD Performance

DFTX152.1%

INDV-0.9%

% from 52W High

DFTX-30.8%

INDV-17.3%

% from 52W Low

DFTX228.5%

INDV50.4%

Asset Turnover (TTM)

DFTX0.00x

INDV1.06x

FCF Yield (TTM)

DFTX-3.9%

INDV-2.5%

Earnings Yield (TTM)

DFTX-8.3%

INDV8.3%

Dividend Yield (TTM)

DFTXN/A

INDVN/A

Rule of 40

DFTX0.0

INDV5.4

EV/GP/RG

DFTXN/A

INDV1.40

Ticker research

View DFTX research View INDV research

Metric	DFTX Definium Therapeutics Inc	INDV Indivior Pharmaceuticals, Inc
Market & Valuation
Market Cap	$4.28B	$4.29B
Enterprise Value	$3.67B	$4.55B
Price	$34.38	$35.42
P/E Ratio	N/A	12.37x
P/S Ratio	0.00x	3.22x
EV/Sales	0.00x	3.42x
EV/EBITDA	0.00x	10.26x
P/B Ratio	5.40x	422.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.83x	-41.75x
PEG Ratio	N/A	0.41x
Forward P/E (NTM)	N/A	7.50x
Forward P/S (NTM)	N/A	3.13x
Revenue & Growth
Revenue (TTM)	$0	$1.33B
Revenue Growth (YoY)	N/A	13.6%
Forward Rev Growth	717.7%	5.4%
Profitability
Gross Margin (TTM)	0.0%	82.0%
Operating Margin (TTM)	0.0%	30.3%
EBITDA Margin (TTM)	0.0%	33.1%
Net Margin (TTM)	0.0%	26.7%
FCF Margin (TTM)	N/A	-8.2%
Net Income (TTM)	$-354M	$355M
FCF (TTM)	$-168M	$-109M
EPS (TTM)	-$3.20	$2.86
ROE (TTM)	-8523.0%	159.1%
ROA (TTM)	-6458.0%	28.1%
ROIC (TTM)	-7781.0%	29.4%
Financial Health
Cash	$655M	$222M
Debt	$36M	$487M
Net Cash/Debt	$619M	$-265M
Current Ratio (TTM)	6.95x	0.84x
Quick Ratio (TTM)	6.89x	0.65x
Debt/Equity (TTM)	0.04x	27.90x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.23	0.49
52W Performance	191.1%	48.9%
YTD Performance	152.1%	-0.9%
% from 52W High	-30.8%	-17.3%
% from 52W Low	228.5%	50.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.06x
FCF Yield (TTM)	-3.9%	-2.5%
Earnings Yield (TTM)	-8.3%	8.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	5.4
EV/GP/RG	N/A	1.40
Ticker research	View DFTX research	View INDV research

Valuation

P/E Ratio

INDV

12.37x

P/S Ratio

DFTX

0.00x

INDV

3.22x

EV/FCF

INDV

-41.75x

DFTX

-21.83x

Growth & revenue

Revenue Growth TTM

INDV

13.6%

Forward Revenue Growth

DFTX

717.7%

INDV

5.4%

Profitability & performance

Gross Margin

INDV

82.0%

DFTX

0.0%

ROE

INDV

159.1%

DFTX

-8523.0%

FCF Yield %

INDV

-2.5%

DFTX

-3.9%

52-Week Performance

DFTX

191.1%

INDV

48.9%

Detailed metrics comparison

DFTX

Definium Therapeutics Inc

INDV

Indivior Pharmaceuticals, Inc

Market Cap

DFTX$4.28B

INDV$4.29B

Enterprise Value

DFTX$3.67B

INDV$4.55B

Price

DFTX$34.38

INDV$35.42

P/E Ratio

DFTXN/A

INDV12.37x

P/S Ratio

DFTX0.00x

INDV3.22x

EV/Sales

DFTX0.00x

INDV3.42x

EV/EBITDA

DFTX0.00x

INDV10.26x

P/B Ratio

DFTX5.40x

INDV422.91x

P/FCF Ratio

DFTXN/A

INDVN/A

EV/FCF

DFTX-21.83x

INDV-41.75x

PEG Ratio

DFTXN/A

INDV0.41x

Forward P/E (NTM)

DFTXN/A

INDV7.50x

Forward P/S (NTM)

DFTXN/A

INDV3.13x

Revenue (TTM)

DFTX$0

INDV$1.33B

Revenue Growth (YoY)

DFTXN/A

INDV13.6%

Forward Rev Growth

DFTX717.7%

INDV5.4%

Gross Margin (TTM)

DFTX0.0%

INDV82.0%

Operating Margin (TTM)

DFTX0.0%

INDV30.3%

EBITDA Margin (TTM)

DFTX0.0%

INDV33.1%

Net Margin (TTM)

DFTX0.0%

INDV26.7%

FCF Margin (TTM)

DFTXN/A

INDV-8.2%

Net Income (TTM)

DFTX$-354M

INDV$355M

FCF (TTM)

DFTX$-168M

INDV$-109M

EPS (TTM)

DFTX-$3.20

INDV$2.86

ROE (TTM)

DFTX-8523.0%

INDV159.1%

ROA (TTM)

DFTX-6458.0%

INDV28.1%

ROIC (TTM)

DFTX-7781.0%

INDV29.4%

Cash

DFTX$655M

INDV$222M

Debt

DFTX$36M

INDV$487M

Net Cash/Debt

DFTX$619M

INDV$-265M

Current Ratio (TTM)

DFTX6.95x

INDV0.84x

Quick Ratio (TTM)

DFTX6.89x

INDV0.65x

Debt/Equity (TTM)

DFTX0.04x

INDV27.90x

Debt/Assets (TTM)

DFTX0.0%

INDV0.0%

Interest Coverage (TTM)

DFTXN/A

INDVN/A

Net Debt/EBITDA (TTM)

DFTX0.00x

INDV0.00x

Beta

DFTX2.23

INDV0.49

52W Performance

DFTX191.1%

INDV48.9%

YTD Performance

DFTX152.1%

INDV-0.9%

% from 52W High

DFTX-30.8%

INDV-17.3%

% from 52W Low

DFTX228.5%

INDV50.4%

Asset Turnover (TTM)

DFTX0.00x

INDV1.06x

FCF Yield (TTM)

DFTX-3.9%

INDV-2.5%

Earnings Yield (TTM)

DFTX-8.3%

INDV8.3%

Dividend Yield (TTM)

DFTXN/A

INDVN/A

Rule of 40

DFTX0.0

INDV5.4

EV/GP/RG

DFTXN/A

INDV1.40

Ticker research

View DFTX research View INDV research

Metric	DFTX Definium Therapeutics Inc	INDV Indivior Pharmaceuticals, Inc
Market & Valuation
Market Cap	$4.28B	$4.29B
Enterprise Value	$3.67B	$4.55B
Price	$34.38	$35.42
P/E Ratio	N/A	12.37x
P/S Ratio	0.00x	3.22x
EV/Sales	0.00x	3.42x
EV/EBITDA	0.00x	10.26x
P/B Ratio	5.40x	422.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.83x	-41.75x
PEG Ratio	N/A	0.41x
Forward P/E (NTM)	N/A	7.50x
Forward P/S (NTM)	N/A	3.13x
Revenue & Growth
Revenue (TTM)	$0	$1.33B
Revenue Growth (YoY)	N/A	13.6%
Forward Rev Growth	717.7%	5.4%
Profitability
Gross Margin (TTM)	0.0%	82.0%
Operating Margin (TTM)	0.0%	30.3%
EBITDA Margin (TTM)	0.0%	33.1%
Net Margin (TTM)	0.0%	26.7%
FCF Margin (TTM)	N/A	-8.2%
Net Income (TTM)	$-354M	$355M
FCF (TTM)	$-168M	$-109M
EPS (TTM)	-$3.20	$2.86
ROE (TTM)	-8523.0%	159.1%
ROA (TTM)	-6458.0%	28.1%
ROIC (TTM)	-7781.0%	29.4%
Financial Health
Cash	$655M	$222M
Debt	$36M	$487M
Net Cash/Debt	$619M	$-265M
Current Ratio (TTM)	6.95x	0.84x
Quick Ratio (TTM)	6.89x	0.65x
Debt/Equity (TTM)	0.04x	27.90x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.23	0.49
52W Performance	191.1%	48.9%
YTD Performance	152.1%	-0.9%
% from 52W High	-30.8%	-17.3%
% from 52W Low	228.5%	50.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.06x
FCF Yield (TTM)	-3.9%	-2.5%
Earnings Yield (TTM)	-8.3%	8.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	5.4
EV/GP/RG	N/A	1.40
Ticker research	View DFTX research	View INDV research